Induction of hemoglobin synthesis by downregulation of MYB protein with an antisense oligodeoxynucleotide

Blood. 1991 Aug 15;78(4):991-6.

Abstract

Reduced expression of the proto-oncogene c-myb appears necessary for erythroid differentiation induced by chemical agents and by the natural regulator, erythropoietin (Epo). Treatment of Epo-responsive Rauscher erythroleukemia cells with an anti-sense oligodeoxynucleotide to c-myb in the absence of other inducers downregulated myb protein markedly and caused hemoglobinization of the cells within 48 hours. Epo treatment, which downregulates c-myb in these cells, induced hemoglobinization to the same degree. Epo also induced the appearance of anion transport protein on the plasma membrane, consistent with terminal differentiation. In contrast, antisense c-myb did not induce this erythroid marker. The results are consistent with a role for myb protein in the regulation of hemoglobin synthesis.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Anion Transport Proteins
  • Carrier Proteins / metabolism
  • Cell Membrane / metabolism
  • Erythropoietin / pharmacology
  • Gene Expression Regulation / drug effects*
  • Hemoglobins / biosynthesis*
  • Humans
  • Leukemia, Erythroblastic, Acute
  • Mice
  • Oligonucleotides, Antisense / pharmacology*
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins / genetics*
  • Proto-Oncogene Proteins / physiology
  • Proto-Oncogene Proteins c-myb
  • Tumor Cells, Cultured

Substances

  • Anion Transport Proteins
  • Carrier Proteins
  • Hemoglobins
  • MAS1 protein, human
  • Oligonucleotides, Antisense
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-myb
  • Erythropoietin